[1]
Nitika Hans 2021. Determining the Efficacy and Safety of Teneligliptin and Metformin Versus Glimepiride and Metformin in Patients of Type-2 Diabetes Mellitus Uncontrolled with Monotherapy. Technological Innovation in Pharmaceutical Research Vol. 10. (Aug. 2021), 46–63. DOI:https://doi.org/10.9734/bpi/tipr/v10/11701D.